Morgan Stanley raised the firm’s price target on Argenx to EUR 477 from EUR 465 and keeps an Overweight rating on the shares.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on ARGX:
- argenx Delivers on Promise to Transform Patient Expectations in Autoimmunity at American Academy of Neurology 2024 Annual Meeting
- Argenx price target lowered to EUR 490 from EUR 510 at JPMorgan
- Argenx price target raised to $440 from $370 at Truist
- Argenx price target raised to $440 from $430 at Guggenheim
- Argenx price target raised to $402 from $346 at Scotiabank
